Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 16 art units • 20 examiners • 0 of 20 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
The Catholic University Of Korea Industry Academic Cooperation Foundation has 1 pending office action. This case is assigned to 1 distinct examiner, WECKER, JENNIFER. As the busiest examiner, WECKER, JENNIFER is handling 1 pending office action. The portfolio's current activity is limited to this single point of interaction within the patent office.
This concentrated prosecution suggests that the foundation is currently focusing its efforts on a specific intellectual property asset. With only 1 distinct examiner involved, the relationship between the applicant and the examiner is the primary factor in the case's progression. Practitioners should prioritize clear communication with WECKER, JENNIFER to ensure the efficient resolution of this pending matter.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (5%) |
| §101 + other | 4 (20%) |
| §103 only | 5 (25%) |
| §112 only | 2 (10%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 7 (35%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JAFFRI, ZEHRA | 1 | 58.8% | +51.8% |
| TERRELL, EMILY C | 1 | 58.7% | +35.7% |
| TATGE, LEXUS MARC | 1 | 50.0% | +100.0% |
| BOWERS, ERIN M | 1 | 54.7% | +10.6% |
| WILSON, MICHAEL C | 1 | 41.5% | +17.9% |
| LEE, TSU-CHANG | 1 | 72.7% | +13.8% |
| WELCH, WILLOW GRACE | 1 | 55.6% | +46.6% |
| ISLAM, MEHRAZUL NMN | 1 | 53.8% | +21.9% |
| KUDO, KEN | 1 | — | — |
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18450703 | METHOD FOR PREDICTING THE OCCURRENCE OF POSTOPERATIVE ACUTE KIDNEY INJURY AND SYSTEM THEREOF | VAN DUZER, ALEXIS KIM | 29d overdue |
| 18362007 | BALLOON DILATATION CATHETER AND ANGIOPLASTY USING THE SAME | SHAH, NILAY J | 25d overdue |
| 18930574 | HYBRID SHUNT SYSTEM FOR CAROTID ENDARTERECTOMY | JAFFRI, ZEHRA | 19d overdue |
| 18297805 | SOLUBLE TREM2 PROTEIN AND USES THEREOF | BUNNER, BRIDGET E | 10d overdue |
| 18434884 | APPARATUS AND METHOD FOR PREDICTING TENDON RE-RUPTURE BASED ON ARTIFICIAL INTELLIGENCE | WELCH, WILLOW GRACE | 9d |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | CANDELARIA, JULIANA IRENE | 14d |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | — |
| 18647191 | METHOD FOR PRODUCING VASCULARIZED RESPIRATORY ORGANOID FUSED WITH BLOOD VESSEL ORGANOID | WILSON, MICHAEL C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18930574 | HYBRID SHUNT SYSTEM FOR CAROTID ENDARTERECTOMY | JAFFRI, ZEHRA | 19d overdue |
| 18434884 | APPARATUS AND METHOD FOR PREDICTING TENDON RE-RUPTURE BASED ON ARTIFICIAL INTELLIGENCE | WELCH, WILLOW GRACE | 9d |
| 18771155 | TUMOR CLASSIFICATION METHOD AND ANALYSIS DEVICE USING MULTI-WAVELENGTH PHOTOACOUSTIC IMAGE AND ULTRASOUND IMAGE | TERRELL, EMILY C | — |
| 18659711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT | TATGE, LEXUS MARC | — |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | — |
| 18647191 | METHOD FOR PRODUCING VASCULARIZED RESPIRATORY ORGANOID FUSED WITH BLOOD VESSEL ORGANOID | WILSON, MICHAEL C | — |
| 18623731 | METHOD FOR GENERATING INFECTIOUS DISEASE PREDICTION KEYWORD THAT CHANGES OVER TIME BASED ON WORD EMBEDDING AND APPARATUS PERFORMING THE SAME | LEE, TSU-CHANG | — |
| 18681231 | METHOD FOR GENERATING OPTIC NERVE PATHWAY USING MRI IMAGE AND OCT IMAGE MATCH | ISLAM, MEHRAZUL NMN | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 3771 | 1 |
| 2666 | 1 |
| 1653 | 1 |
| 3796 | 1 |
| 2662 | 1 |
| 2671 | 1 |
| 1618 | 1 |
| 1625 | 1 |
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18930574 | HYBRID SHUNT SYSTEM FOR CAROTID ENDARTERECTOMY | JAFFRI, ZEHRA | 3771 | §102§103§112 | Final Rejection | 19d overdue | Pending | Oct 29, 2024 |
| 18771155 | TUMOR CLASSIFICATION METHOD AND ANALYSIS DEVICE USING MULTI-WAVELENGTH PHOTOACOUSTIC IMAGE AND ULTRASOUND IMAGE | TERRELL, EMILY C | 2666 | §112 | Final Rejection | — | Pending | Jul 12, 2024 |
| 18659711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT | TATGE, LEXUS MARC | — | §112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | 1653 | §101§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18647191 | METHOD FOR PRODUCING VASCULARIZED RESPIRATORY ORGANOID FUSED WITH BLOOD VESSEL ORGANOID | WILSON, MICHAEL C | — | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18623731 | METHOD FOR GENERATING INFECTIOUS DISEASE PREDICTION KEYWORD THAT CHANGES OVER TIME BASED ON WORD EMBEDDING AND APPARATUS PERFORMING THE SAME | LEE, TSU-CHANG | — | §101 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18434884 | APPARATUS AND METHOD FOR PREDICTING TENDON RE-RUPTURE BASED ON ARTIFICIAL INTELLIGENCE | WELCH, WILLOW GRACE | 3796 | §101§103§112 | Non-Final OA | 9d | Pending | Feb 07, 2024 |
| 18681231 | METHOD FOR GENERATING OPTIC NERVE PATHWAY USING MRI IMAGE AND OCT IMAGE MATCH | ISLAM, MEHRAZUL NMN | 2662 | §103 | Final Rejection | — | Pending | Feb 05, 2024 |
| 18385925 | ELECTRONIC DEVICE FOR AI-BASED RECOMMENDATION OF MELANOMA BIOPSY SITE AND METHOD FOR PERFORMING THE SAME | KUDO, KEN | 2671 | §103 | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18288667 | CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF | DONOHUE, SEAN R | 1618 | §103§112 | Final Rejection | — | Pending | Oct 27, 2023 |
| 18286677 | PHARMACEUTICAL COMPOSITION COMPRISING NOVEL SD911 COMPOUND AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF TRANSPLANT REJECTION | KENYON, JOHN S | 1625 | §112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18377504 | DEVICE MEASURING THE DEFOCUS CURVE OF A MULTIFOCAL INTRAOCULAR LENS | FABIAN JR, ROBERTO | 2877 | §103 | Non-Final OA | 30d overdue | Pending | Oct 06, 2023 |
| 18370598 | COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS | COUGHLIN, DANIEL F | 1619 | §103 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18450703 | METHOD FOR PREDICTING THE OCCURRENCE OF POSTOPERATIVE ACUTE KIDNEY INJURY AND SYSTEM THEREOF | VAN DUZER, ALEXIS KIM | 3682 | §101§103§112 | Non-Final OA | 29d overdue | Pending | Aug 16, 2023 |
| 18362007 | BALLOON DILATATION CATHETER AND ANGIOPLASTY USING THE SAME | SHAH, NILAY J | 3783 | §102§103 | Final Rejection | 25d overdue | Pending | Jul 31, 2023 |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | CANDELARIA, JULIANA IRENE | 1634 | §103§112 | Final Rejection | 14d | Pending | Jun 28, 2023 |
| 18254912 | METHOD FOR FABRICATING MICROROBOT FOR DELIVERY OF CELL THERAPY PRODUCT AND MICROROBOT ACCORDING THERETO | MACH, ANDRE | 1615 | §103 | Final Rejection | 26d | Pending | May 30, 2023 |
| 18035894 | ANTIBODY-BASED CONJUGATE FOR ENHANCING THERAPEUTIC EFFECT OF TARGETED THERAPEUTIC AGENT | DAHLE, CHUN WU | 1641 | §102§103§112 | Non-Final OA | — | Pending | May 08, 2023 |
| 18297805 | SOLUBLE TREM2 PROTEIN AND USES THEREOF | BUNNER, BRIDGET E | 1647 | §101§102§112 | Final Rejection | 10d overdue | Pending | Apr 10, 2023 |
| 17268635 | PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES | RIGA, MICHAEL ANGELO | 1634 | §103§112 | Final Rejection | — | Pending | Feb 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial